We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Precipio, Inc (PRPO) is a leading diagnostics & research business with stocks listed in the US. It opened the day at US$2.25 after a previous close of US$2.18. During the day the price has varied from a low of USD2.15 to a high of USD2.33. The latest price was USD2.17 (25 minute delay). Precipio is listed on the NASDAQ. All prices are listed in US Dollars.
How to buy shares in Precipio
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Precipio. Find the share by name or ticker symbol: PRPO. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Precipio reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$2.58, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Precipio, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Precipio. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
🧪How we chose these brokersFor our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.
What's in this guide?
Precipio share priceUse our graph to track the performance of PRPO stocks over time.
Precipio shares at a glance
|52-week range||US$0.55 - US$5|
|50-day moving average||US$2.9155|
|200-day moving average||US$2.4048|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||US$-5.807|
Compare share trading platforms
Is it a good time to buy Precipio stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Precipio price performance over time
|1 week (2021-02-26)||N/A|
|1 month (2021-02-05)||N/A|
|3 months (2020-12-05)||N/A|
|6 months (2020-09-05)||N/A|
|1 year (2020-03-05)||N/A|
|2 years (2019-03-05)||N/A|
|3 years (2018-03-05)||N/A|
|5 years (2016-03-05)||N/A|
|Revenue TTM||US$4.8 million|
|Gross profit TTM||US$219,000|
|Return on assets TTM||-27.7%|
|Return on equity TTM||-85.82%|
|Market capitalisation||US$43.2 million|
TTM: trailing 12 months
Shorting Precipio shares
There are currently 1.1 million Precipio shares held short by investors – that's known as Precipio's "short interest". This figure is 2.6% down from 1.2 million last month.
There are a few different ways that this level of interest in shorting Precipio shares can be evaluated.
Precipio's "short interest ratio" (SIR)
Precipio's "short interest ratio" (SIR) is the quantity of Precipio shares currently shorted divided by the average quantity of Precipio shares traded daily (recently around 1.4 million). Precipio's SIR currently stands at 0.8. In other words for every 100,000 Precipio shares traded daily on the market, roughly 800 shares are currently held short.
However Precipio's short interest can also be evaluated against the total number of Precipio shares, or, against the total number of tradable Precipio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Precipio's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Precipio shares in existence, roughly 70 shares are currently held short) or 0.0674% of the tradable shares (for every 100,000 tradable Precipio shares, roughly 67 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Precipio.
Find out more about how you can short Precipio stock.
Precipio share dividends
We're not expecting Precipio to pay a dividend over the next 12 months.
Have Precipio's shares ever split?
Precipio's shares were split on a 1:15 basis on 29 April 2019. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Precipio shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Precipio shares which in turn could have impacted Precipio's share price.
Precipio share price volatility
Over the last 12 months, Precipio's shares have ranged in value from as little as US$0.55 up to US$5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Precipio's is 2.8761. This would suggest that Precipio's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Precipio, Inc., a cancer diagnostics company, provides diagnostic products and services in the United States oncology market. Its product consists of clinical diagnostic services. The company's clinical diagnostic services focus on the diagnosis of different hematopoietic or blood-related cancers to oncologists. Its cytogenetics media IV-Cell enables laboratories to arrive at more accurate results; and HemeScreen panel enables hospitals and laboratories to run an important genetic mutation test. It serves oncologists, hospitals, reference laboratories, and pharma and biotech companies. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, such as the Yale School of Medicine and Harvard's Dana-Farber Cancer Institute. The company is based in New Haven, Connecticut.
Frequently asked questions
More guides on Finder
How to buy Althea Group shares | A$N/A
Steps to owning and managing Althea Group shares.
How to buy AusCann Group shares
Steps to owning and managing AusCann Group shares.
How to buy Eastman Kodak Company shares
Steps to owning and managing Kodak shares from Australia.
How to buy Sorrento Therapeutics shares
Steps to owning and managing Sorrento Therapeutics shares from Australia.
How to buy Kandi Technologies Group shares
Steps to owning and managing Kandi Technologies shares from Australia.
How to buy Taoping shares
Steps to owning and managing Taoping shares from Australia.
How to buy American Airlines Group shares
Steps to owning and managing American Airlines shares from Australia.
How to buy MGM Resorts International shares
Steps to owning and managing MGM Resorts shares.
How to buy ADT shares
Steps to owning and managing ADT shares from Australia.
How to buy Rocket Companies shares
Steps to owning and managing Rocket Companies shares from Australia.
Ask an Expert